Most commonly used adjuvants in therapeutic cancer trials
| Number of studies including most commonly used adjuvants/immunostimulants | ||||
|---|---|---|---|---|
| Adjuvant | Phase 2 | Phase 2/3 | Phase 3 | Total |
| GM-CSF | 92 | 1 | 16 | 109 |
| Montanide | 60 | 1 | 5 | 66 |
| IL-2 | 53 | 3 | 56 | |
| KLH | 16 | 8 | 24 | |
| TRICOM | 10 | 3 | 13 | |
| QS21 | 5 | 1 | 6 | |
| Poly-ICLC | 8 | 0 | 0 | 8 |